140 related articles for article (PubMed ID: 27110732)
1. The Diagnostic Value of MR Imaging in Determining the Lymph Node Status of Patients with Non-Small Cell Lung Cancer: A Meta-Analysis.
Peerlings J; Troost EG; Nelemans PJ; Cobben DC; de Boer JC; Hoffmann AL; Beets-Tan RG
Radiology; 2016 Oct; 281(1):86-98. PubMed ID: 27110732
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
Shen G; Hu S; Deng H; Jia Z
Acta Radiol; 2015 Jun; 56(6):681-7. PubMed ID: 24917609
[TBL] [Abstract][Full Text] [Related]
3. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.
Nakayama J; Miyasaka K; Omatsu T; Onodera Y; Terae S; Matsuno Y; Cho Y; Hida Y; Kaga K; Shirato H
J Comput Assist Tomogr; 2010 Jan; 34(1):1-8. PubMed ID: 20118713
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
Xu L; Tian J; Liu Y; Li C
J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
[TBL] [Abstract][Full Text] [Related]
5. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging.
Ohno Y; Hatabu H; Takenaka D; Higashino T; Watanabe H; Ohbayashi C; Yoshimura M; Satouchi M; Nishimura Y; Sugimura K
Radiology; 2004 Jun; 231(3):872-9. PubMed ID: 15163823
[TBL] [Abstract][Full Text] [Related]
6. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
[TBL] [Abstract][Full Text] [Related]
7. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Maniwa Y; Nishio W; Nishimura Y; Itoh T; Sugimura K
Radiology; 2011 Nov; 261(2):605-15. PubMed ID: 21926377
[TBL] [Abstract][Full Text] [Related]
8. Nodal metastasis in non-small cell lung cancer: accuracy of 3.0-T MR imaging.
Kim HY; Yi CA; Lee KS; Chung MJ; Kim YK; Choi BK; Kim H; Kwon OJ
Radiology; 2008 Feb; 246(2):596-604. PubMed ID: 18056854
[TBL] [Abstract][Full Text] [Related]
9. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
[TBL] [Abstract][Full Text] [Related]
10. Performance of DWI in the Nodal Characterization and Assessment of Lung Cancer: A Meta-Analysis.
Shen G; Hu S; Deng H; Kuang A
AJR Am J Roentgenol; 2016 Feb; 206(2):283-90. PubMed ID: 26587799
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis.
Hoshino N; Murakami K; Hida K; Sakamoto T; Sakai Y
Int J Clin Oncol; 2019 Jan; 24(1):46-52. PubMed ID: 30259217
[TBL] [Abstract][Full Text] [Related]
12. The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
AJR Am J Roentgenol; 2018 Mar; 210(3):W95-W109. PubMed ID: 29381380
[TBL] [Abstract][Full Text] [Related]
13. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.
Thoeny HC; Froehlich JM; Triantafyllou M; Huesler J; Bains LJ; Vermathen P; Fleischmann A; Studer UE
Radiology; 2014 Oct; 273(1):125-35. PubMed ID: 24893049
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
15. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
18. Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis.
Wu LM; Xu JR; Liu MJ; Zhang XF; Hua J; Zheng J; Hu JN
Acad Radiol; 2012 Mar; 19(3):331-40. PubMed ID: 22153656
[TBL] [Abstract][Full Text] [Related]
19. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
20. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
